Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiro Suzuki

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 22, 2019
[A CASE WITH LATE RECURRENCE OF EXTRAGONADAL GERM CELL TUMOR]Aya Mori, Yasuhito Funahashi, Satoshi Inoue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402Akira Inoue, Shunichi Sugawara, Koichi Yamazaki, et al.
Respiratory Investigation|May 24, 2014
Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802Yosuke Kawashima, Akira Inoue, Shunichi Sugawara, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901Naoto Morikawa, Akira Inoue, Shunichi Sugawara, et al.
Cancer Chemotherapy and Pharmacology|April 14, 2018
Antiproteinuric effects of renin-angiotensin inhibitors in lung cancer patients receiving bevacizumabSatoru Nihei, Junya Sato, Toshiyuki Harada, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2020
Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapyYusuke Okuma, Ryo Ko, Takehito Shukuya, et al.
Cancer Science|May 14, 2020
Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinomaTakahiro Osawa, Takahiro Kojima, Tomohiko Hara, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 22, 2019
[A CASE WITH LATE RECURRENCE OF EXTRAGONADAL GERM CELL TUMOR]Aya Mori, Yasuhito Funahashi, Satoshi Inoue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402Akira Inoue, Shunichi Sugawara, Koichi Yamazaki, et al.
Respiratory Investigation|May 24, 2014
Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802Yosuke Kawashima, Akira Inoue, Shunichi Sugawara, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901Naoto Morikawa, Akira Inoue, Shunichi Sugawara, et al.
Cancer Chemotherapy and Pharmacology|April 14, 2018
Antiproteinuric effects of renin-angiotensin inhibitors in lung cancer patients receiving bevacizumabSatoru Nihei, Junya Sato, Toshiyuki Harada, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2020
Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapyYusuke Okuma, Ryo Ko, Takehito Shukuya, et al.
Cancer Science|May 14, 2020
Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinomaTakahiro Osawa, Takahiro Kojima, Tomohiko Hara, et al.
Pageof 4